Tarsus Pharmaceuticals, Inc. Business Finance Contracts & Agreements
11 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (1)
- Form of Pre-Funded Warrant (Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated February 29, 2024, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC (Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated August 1, 2023, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC (Filed With SEC on August 2, 2023)
- Loan and Security Agreement, dated February 2, 2022, by and among (Filed With SEC on May 11, 2022)
- Underwriting Agreement, dated May 2, 2022, by and among the Company, BofA Securities, Inc. and Jefferies LLC (Filed With SEC on May 4, 2022)
- Tarsus Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 9, 2020)
- Amended and Restated Investors Rights Agreement, dated September 24, 2020, by and among the Registrant and the other parties thereto (Filed With SEC on October 9, 2020)
- Form of Registrants common stock certificate (Filed With SEC on October 9, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 9, 2020)
- Tarsus Pharmaceuticals, Inc. 2016 Stock Plan, as amended, and forms of agreements thereunder (Filed With SEC on September 25, 2020)
- Second Amendment to Loan and Security Agreement, dated as of August 28, 2023, by and among Registrant, Hercules Capital, Inc. and First-Citizens Bank & Trust Company (Filed With SEC on November 9, 2023)
